Intellectual Property

ISB is committed to ensuring that discoveries resulting from its research will be used to benefit society. An important aspect of this knowledge and technology transfer is the licensing of its intellectual property to companies which can effectively translate and develop inventions into commercially available products and services. ISB regularly evaluates its research discoveries to determine whether they are appropriate to patent and, if so, how they can best be commercialized.


In some cases, patent rights have been licensed to existing companies in exchange for royalties and other fees. In addition, ISB technologies have also formed the basis for start-up companies, including Cytopeia, Nanostring and Integrated Diagnostics, in which ISB has taken an equity interest. Such commercialization activities are mutually beneficial in promoting the development of new products and services while producing resources to support ISB’s continuing research.